AbbVie Set to Sell $10 Billion in Bonds to Fund Apogee Deal
AbbVie Inc. has launched a $10 billion investment-grade bond sale to help fund its pending acquisition of fellow drugmaker Apogee Therapeutics Inc.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.